Clinical Trial Update: A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of an ophthalmic solution (SkQ1) for dry eye syndrome completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Keratoconjunctivitis Sicca

Drugs mentioned

• SkQ1 ophthalmic solution (SkQ1)

Snippet

Sponsor: Mitotech, SA | Conditions: Keratoconjunctivitis Sicca | Phase 2 | Status: COMPLETED | Results posted: 2020-10-14